期刊文献+

脑卒中胸大肌痉挛患者肉毒毒素A治疗的疗效观察 被引量:3

Curative Effectiveness of Botulinum Toxin Type A for Pectoralis Major Muscle Spasm in Stroke Patients
下载PDF
导出
摘要 目的:评价A型肉毒毒素(BTXA)治疗胸大肌痉挛的疗效。方法:脑卒中偏瘫并发胸大肌痉挛患者48例,随机分为BTXA组和对照组各24例,均按脑卒中常规康复方案治疗。BTXA组患者并行胸大肌BTXA注射(100 U及2 ml生理盐水)1次。治疗前和治疗后1个月行胸大肌肌张力Asworth评分,肩关节外展、外旋和前屈被动活动度测量,肩关节疼痛VAS评分,ADL评分。结果:治疗1个月后,2组胸大肌肌张力Asworth及VAS评分均有下降、肩关节被动活动度明显提高(P<0.05);2组间比较,BTXA组表现更明显(P<0.01)。ADL评分,2组治疗前后比较均差异无统计学意义。结论:BTXA注射可以减轻脑卒中胸大肌痉挛,改善肩关节活动度,缓解肩部疼痛。 Objective:To study the efficacy of botulinum toxin type A(BTXA) for the treatment of pectoralis major muscle spasm in stroke patients.Methods:Forty-eight patients were randomly divided into two groups:therapy group(24 cases) and control group(24 cases).The patients in therapy group were given intramuscular injection of BTXA in the pectoralis major muscle and regularly physical therapy,and those in control group given regularly physical therapy only.Patients were assessed by using Visual Analogue Scale(VAS) for shoulder pain.Spasticity was measured by the modified Ashworth scale(MAS).The passive range of motion(PROM) about shoulder was measured in 3 directions:inflexion,extension and external rotation.Activities of daily living(ADL) were also assessed.Measurements were made at baseline and one month after injection.Results:The improvement of score of MAS,VAS,and PROM in therapy group was obviously superior to that in control group(P0.05),but there was no significant difference in the score of ADL in two groups before and after treatment.Conclusion:The injection of BTXA into pectoralis major muscle can relieve spasm of pectoralis major muscle,improve PROM of shoulder and relieve the shoulder pain.
出处 《中国康复》 2011年第1期25-27,共3页 Chinese Journal of Rehabilitation
关键词 脑卒中 胸大肌痉挛 A型肉毒毒素 stroke pectoralis major muscle spasm botulinum toxin type A
  • 相关文献

参考文献8

二级参考文献17

  • 1余明市,黄光,付明市,刘冀清.肌电图导引下A型肉毒毒素治疗脑卒中肢体痉挛疗效观察[J].中国康复理论与实践,2004,10(12):742-743. 被引量:9
  • 2王荫椿.肉毒毒素及其临床应用(综述)[J].中国神经免疫学和神经病学杂志,1996,3(2):124-127. 被引量:56
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 4李琪.肉毒素A治疗痉挛状态、肌痉挛和肌强直[J].国外医学:神经病学.神经外科学分册,1996,23(4):214-214.
  • 5Wissel J,Ward AB,Erztgaard P,et al.European consensus table on the use of botulinum toxin type A in adult spasticity[J].J Rehabil Med,2009,41(1):13-25.
  • 6Royal College of Physicians.Spasticity in adults:management using botulinum toxin,National guidelines January 2009 (www.rcplondon.ac.uk).
  • 7Mayer NH,Esquenazi A.Upper Limb Skin and Musculoskeletal Consequences of the Upper Motor Neuron Syndrome.Botulinnm toxin:Therapeutic clinical and practice science[M].Saunders Elsvier,2009.131-147.
  • 8DENISLIC M,PIRTOSEK Z,VODUSEK DB,et al.Botulinum Toxin in the Treatment of Neurological Disorsers[J].Annals New York Academy of Sciences(S1460-2199),1994,710:76-87.
  • 9BOBATH B.Adult Hemiplegia Evaluation And Treatment[M].London:WilliamHeinemonn Medical Books,1978.
  • 10BRIN MF.Botulinum Toxin:Chemistry,Pharmacology,Toxi-city and Immunology[J].Muscle Nerve Suppl(S0148-639X),1997,6:S146-168.

共引文献98

同被引文献32

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部